维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Hanauer J"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Systematic review:the pharma-cokinetic profiles of oral mesalazine formulations andmesalazine pro-drugs used in the management of ulcerativecolitis显示文摘	Sandborn W J Hanauer SB	2003	Aliment Pharmacol Ther2003，17，1：	1
2	Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial显示文摘	William J Sandborn Daniel H Present Kim L Isaacs Douglas C Wolf Eugene Greenberg Stephen B Hanauer Brian G Feagan Lloyd Mayer Therese Johnson Joseph Galanko Christopher Martin Robert S Sandler	2003	Gastroenterology2003，，2：	1
3	Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation显示文摘	Sunanda V Kane William J Sandborn Paul A Rufo Anna Zholudev James Boone David Lyerly Michael Camilleri Stephen B Hanauer	2003	The American Journal of Gastroenterology2003，，：	1
4	Etanereept for active Crohn's disease: a randomized, double-blind, placebo-con- trolled trial 显示文摘	Sandborn W J Hanauer SB Katz S	2001	Gastroenterology2001，121，5：	1
5	Mesalamine capsules for treatment of active ulcerative colitis : results of a controlled trial显示文摘	Hanauer S Schwartz J Robinson M	1993	Am J Gastroenterol1993，88，8：	1
6	Human anti-tumor necrosis factor monoclonal antibody (adalimumab)in Crohn's disease显示文摘	Hanauer S B Sandbom W J Rutgeerts P	2006	Gastroenterology2006，130，2：	1
7	Management of Crohn's disease in adults 显示文摘	Lichtenstein GR Hanauer SB Sandborn W J Practice Parameters Committee of American College of Gastro- enterology	2009	Am J Gastroenterol2009，104，2：	1
8	A Shoty-term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor Alpha for Crohn's Disease cA2 Study Group显示文摘	Targan S R Hanauer S B Van Deventer S J	1997	N Engl J Med1997，337，：	1
9	Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine(Asacol)and balsalazide:a randomized,single-dose,crossover study inhealthy volunteers显示文摘	Sandborn W J Hanauer SB Buch A		0，，：	1
10	A short-term study of chimeric monoclonal antibody CA 2 to tumor necrosis factor alpha for Crohn's Disease显示文摘	Targan S R Hanauer S B Van Deventer S J	1997	N Engl J Med1997，337，15：	1
11	Mesalamine capsules for treatment of active ulcerative colitis:results of a controlled trial显示文摘	Hanauer S Schwartz J Robinson M	1993	Am J Gastroenterol1993，88，8：	1
12	Systematic review:the pharma2 cokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis显示文摘	SANDBORN W J HANAUER S B	2003	Aliment Pharmacol Ther2003，17，：	1
13	A randomized,double-blind,placebo-contralled,multi-center trial of the engineered human antibody to TNF(CDP571) for steroid sparing znd maintenance of remission in patients with steroid-dependent Crohn'sdisease显示文摘	Feagan BG Sandborn WJ Baker J Comineli F Sutherland LR Elson C Salzberg B Archambault A Bernstein C Lichtenstein G Heath PK Hanauer SB	2000	Gastroenterology2000，118，：	1
14	AGA technical review on perianal Crohn’s disease显示文摘	William J Sandborn Victor W Fazio Brian G Feagan Stephen B Hanauer	2003	Gastroenterology2003，，5：	1
15	Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis 显示文摘	SANDBORN W J HANAUER S B	2003	Aliment Pharmacol Ther2003，17，1：	1
16	Medical therapy to reduce post operative Crohn's disease recurrence显示文摘	Achkar J P Hanauer S B	2000	Am J Gastroenterol2000，95，：	1
17	Gastrointestinal symptoms associated with orthostatic intolerance显示文摘	Sullivan SD Hanauer J Rowe PC	2005	J Pediatr Gastroenterol Nutr2005，40，4：	1
18	Management of Crohn' s disease in adults显示文摘	LICHTENSTEIN G R HANAUER S B SANDBOM W J	2009	Am J Gastroenterol2009，104，：	1
19	Budes- onide CIR capsules ( once or twice daily divided dose) in active crohn's disease:a randomized placebo- controlled study in the United States 显示文摘	TREMAINE W J HANAUER S B KATZ S	2002	Am J Gastroenterol2002，97，7：	1
20	H u m a n anti-tumornecrosis factor monoclonal antibody ( adalimumab) in Crohn’sdisease ; the CLASSIC-I trial 显示文摘	Hanauer S B Sandbom W J Rutgeerts P	2006	Gastroenterology - 20062006，591，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示